Infection Control and Hospital Epidemiology Publication Info
For individual subscriptions, please contact the The University of Chicago Press
University of Chicago Press Customer Service:
1.877.705.1878 (toll-free, U.S. & Canada)
1.773.753.3347 (international)
subscriptions@press.uchicago.edu
For information about institutional access to this title, please visit the Institutional Subscriptions page.
Cost‐Effectiveness of Perirectal Surveillance Cultures for Controlling Vancomycin‐Resistant Enterococcus
Formats Available in JSTOR: PDF
Abstract(back to top)
BACKGROUND. Several hospitals opting not to use active surveillance cultures to identify carriers of vancomycin‐resistant Enterococcus (VRE) have reported that adoption of other parts of the Centers for Disease Control and Prevention guideline for controlling VRE has had little to no impact. Because use of surveillance cultures and contact isolation controlled a large outbreak at this hospital, their costs were estimated for comparison with the excess costs of VRE bacteremias occurring at a higher rate at a hospital not employing these measures.
SETTING. Two university hospitals.
METHODS. Inpatients deemed high risk for VRE acquisition at this hospital underwent weekly perirectal surveillance cultures. Estimated costs of cultures and resulting isolation during a 2‐year period were compared with the estimated excess costs of more frequent VRE bacteremias at another hospital of similar size and complexity not using surveillance cultures to control spread throughout the hospital.
RESULTS. Of 54,052 patients admitted, 10,400 had perirectal swabs taken. Cultures and isolation cost an estimated $253,099. VRE culture positivity was limited to 193 (0.38%) and VRE bacteremia to 1 (0.002%) as compared with 29 bacteremias at the comparison hospital. The estimated attributable cost of VRE bacteremia at the comparison hospital of $761,320 exceeded the cost of the control program at this hospital by threefold.
CONCLUSIONS. The excess costs of VRE bacteremia may justify the costs of preventive measures. The costs of VRE infections at other body sites, of deaths from untreatable infections, and of dissemination of genes for vancomycin resistance also help to justify the costs of implementing an effective control program.
Bibliographic Information(back to top)
- Cost‐Effectiveness of Perirectal Surveillance Cultures for Controlling Vancomycin‐Resistant Enterococcus
- Carlene A. Muto , MD, MS, Eve T. Giannetta , RN, Lisa J. Durbin , BS, MT (ASAP), Barbara M. Simonton , CLT (HEW) and Barry M. Farr , MD, MSc
- Infection Control and Hospital Epidemiology
- Vol. 23, No. 8 (August 2002) (pp. 429-435)
Notes and References(back to top)
This item contains 1 note(s).
Notes
The authors are from the University of Virginia Health System, Charlottesville, Virginia. Address reprint requests to Barry M. Farr, MD, MSc, Box 473, University of Virginia Health System, Charlottesville, VA 22908. Presented at the Ninth Annual Meeting of the Society for Healthcare Epidemiology of America; April 18‐20, 1999; San Francisco, CA.
Items Citing this Item (back to top)
19 item(s) in JSTOR cite this item
- Daniel J. Morgan , MD; Hannah R. Day , MS; Jon P. Furuno , PhD; Atlisa Young , MSW; J. Kristie Johnson , PhD; Douglas D. Bradham , PhD; Eli N. Perencevich , MD, MSVol. 31, No. 12 (December 2010) pp. 1230-1235Stable URL: http://www.jstor.org/stable/10.1086/657335
- Michael S. Calderwood , MD; Andreas Mauer , MD; Jocelyn Tolentino , MPH; Ernesto Flores , MT(ASCP), CIC; Koen van Besien , MD; Ken Pursell , MD; Stephen G. Weber , MD, MSVol. 29, No. 11 (November 2008) pp. 1019-1025Stable URL: http://www.jstor.org/stable/10.1086/591454
- Eli N. Perencevich , MD, MS; Patricia W. Stone , PhD, MPH, RN; Sharon B. Wright , MD, MPH; Yehuda Carmeli , MD, MPH; David N. Fisman , MD, MPH, FRCP(C); Sara E. Cosgrove , MD, MSVol. 28, No. 10 (October 2007) pp. 1121-1133Stable URL: http://www.jstor.org/stable/10.1086/521852
- Barry M. Farr , MD, MScVol. 28, No. 5 (May 2007) pp. 589-593Stable URL: http://www.jstor.org/stable/10.1086/515710
- Stephen G. Weber , MD, MS; Susan S. Huang , MD, MPH; Shannon Oriola , RN, CIC, COHN; W. Charles Huskins , MD, MSc; Gary A. Noskin , MD; Kathleen Harriman , PhD, MPH, RN; Russell N. Olmsted , MPH, CIC; Marc Bonten , MD, PhD; Tammy Lundstrom , MD, JD; Michael W. Climo , MD; Mary‐Claire Roghmann , MD, MS; Cathryn L. Murphy , MPH, PhD, CIC; Tobi B. Karchmer , MD, MSVol. 28, No. 3 (March 2007) pp. 249-260Stable URL: http://www.jstor.org/stable/10.1086/512261
- Barry M. Farr , MD, MScVol. 27, No. 10 (October 2006) pp. 1096-1106Stable URL: http://www.jstor.org/stable/10.1086/508759
- Brooke N. Shadel , PhD, MPH; Laura A. Puzniak , PhD, MPH; Kathleen N. Gillespie , PhD; Steven J. Lawrence , MD; Marin Kollef , MD; Linda M. Mundy , MDVol. 27, No. 10 (October 2006) pp. 1068-1075Stable URL: http://www.jstor.org/stable/10.1086/507960
- Barry M. Farr , MD, MScVol. 27, No. 10 (October 2006) pp. 999-1003Stable URL: http://www.jstor.org/stable/10.1086/508672
- Erika M. C. D'Agata, Glenn Webb, MaryAnn HornVol. 192, No. 11 (Dec. 1, 2005) pp. 2004-2011Stable URL: http://www.jstor.org/stable/30086392
- Nalini Singh , MD, MPH; Marie‐Michèle Léger , PA‐C, MPH; Joyce Campbell , RN, MS; Billie Short , MD; Joseph M. Campos , PhDVol. 26, No. 7 (July 2005) pp. 646-649Stable URL: http://www.jstor.org/stable/10.1086/502595
- Todd A. Lee , PharmD, PhD; Donna M. Hacek , MT (ASCP); Kevin T. Stroupe , PhD; Susan M. Collins , MT (ASCP); Lance R. Peterson , MDVol. 26, No. 1 (January 2005) pp. 39-46Stable URL: http://www.jstor.org/stable/10.1086/502485
- Laura A. Puzniak , PhD; Kathleen N. Gillespie , PhD; Terry Leet , PhD; Marin Kollef , MD; Linda M. Mundy , MDVol. 25, No. 5 (May 2004) pp. 418-424Stable URL: http://www.jstor.org/stable/10.1086/502416
- Jon Rosenberg , MD; William R. Jarvis , MD; Sharon L. Abbott , MS; Duc J. Vugia , MD, MPH; for theVol. 25, No. 5 (May 2004) pp. 408-412Stable URL: http://www.jstor.org/stable/10.1086/502414
- Keryn J. Christiansen , MBBS, FRCPA; Patricia A. Tibbett , RN, BAppSc; William Beresford , MBChB, FAFPHM; John W. Pearman , MD, FRCPA; Rosie C. Lee , RN, BNsg; Geoffrey W. Coombs , BAppSc; Ian D. Kay , BAppSc; Frances G. O’Brien , BAppSc; Silvano Palladino , BAppSc, MHthMgt; Charles R. Douglas , MBBS, FAFPHM; Philip D. Montgomery , MBBS, FRACMA; Terri Orrell , RN, BNsg; Allison M. Peterson , RN, BNsg; Frank P. Kosaras , BAppSc; James P. Flexman , PhD, FRCPA; Christopher H. Heath , FRCPA, FRACP; Cheryll A. McCullough , BAppScVol. 25, No. 5 (May 2004) pp. 384-390Stable URL: http://www.jstor.org/stable/10.1086/502410
- Anthony D. Harris , MD, MPH; Lucia Nemoy , MD; Judith A. Johnson , PhD; Amy Martin‐Carnahan , PhD; David L. Smith , PhD; Hal Standiford , MD; Eli N. Perencevich , MD, MSVol. 25, No. 2 (February 2004) pp. 105-108Stable URL: http://www.jstor.org/stable/10.1086/502358
- M. EdmondVol. 24, No. 5 (May 2003) pp. 309-302Stable URL: http://www.jstor.org/stable/10.1086/503479
- J. M. Munoz; A. E. MaciasVol. 24, No. 5 (May 2003) pp. 312-313Stable URL: http://www.jstor.org/stable/10.1086/503480
- Carlene A. Muto , MD, MS; John A. Jernigan , MD, MS; Belinda E. Ostrowsky , MD, MPH; Hervé M. Richet , MD; William R. Jarvis , MD; John M. Boyce , MD; Barry M. Farr , MD, MScVol. 24, No. 5 (May 2003) pp. 362-386Stable URL: http://www.jstor.org/stable/10.1086/502213
- C. Glen Mayhall , MDVol. 23, No. 8 (August 2002) pp. 420-423Stable URL: http://www.jstor.org/stable/10.1086/502078